Advances in paediatric neuropsychopharmacology: an overview.
This Special Section of Int J Neuropsychopharmacol highlights current progress in paediatric neuropsychopharmacology. Combining critical reviews and, in some cases, new data, specific topics include: biological findings in major depression, sleep dysregulation in depressed youth, cardiovascular and ventilatory dysregulation in panic disorder, paediatric autoimmune neuropsychiatric disorder associated with strep (PANDAS), age of onset as a subtype marker in tic and obsessive--compulsive disorders (OCD), functional and pharmaconeuroanatomy of OCD and the behavioural pharmacokinetics of methylphenidate. In this introductory section, these articles are placed in the context of the state-of-the field and, more specifically, within the framework of recent NIMH initiatives in paediatric neuropsychopharmacology.
March
J S
JS
Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA. jsmarch@acpub.duke.edu
Vitiello
B
B
D000293:Adolescent; D015551:Autoimmunity; D002648:Child; D003865:Major Depressive Disorder / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D009316:National Institutes of Health (U.S.); D009480:Neuropharmacology / Q000639:trends*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D016584:Panic Disorder / Q000188:drug therapy; D010372:Pediatrics / Q000639:trends*; D011600:Psychopharmacology / Q000639:trends*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy; D013290:Streptococcal Infections / Q000276:immunology / Q000523:psychology; D014481:United States
D011619:Psychotropic Drugs